New HIV pill STP0404 shows promise in small trial
Disease control
Completed
This phase 2a trial tested a new experimental drug called STP0404 (Pirmitegravir) in 25 adults with HIV-1 who had never taken HIV medications before. Participants received either a low, medium, or high dose of STP0404 or a placebo once daily for 10 days. The study measured how we…
Phase: PHASE2 • Sponsor: ST Pharm Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC